Clinical Response Prediction: New Service from Bayer Technology Services and Physiomics
Bayer Technology Services and the systems biology company Physiomics plc announced a collaborative agreement to cooperate in the field of clinical response prediction. Clinical response prediction measures the optimum dosing and efficacy of therapeutic compounds. The new service brings together two unique strengths in systems biology – the Bayer Technology Services’ PK-Sim® physiology-based pharmacokinetic (PBPK) modeling and Physiomics’ SystemCell technology which can determine and predict optimum drug levels. The collaboration reflects the growing demand from the pharmaceutical and biotechnology industries for simulation technology to streamline drug discovery from pre-clinical through Phase III.
Clinical response prediction is designed to smooth out dosing and related toxicity problems early in a drug’s development. Integrating pharmacokinetic and pharmacodynamic technologies into one predictive system aids portfolio attrition risk assessment, clinical protocol optimization and project troubleshooting. The integrated approach delivers quantitative arguments for prioritization of drug candidates in a pipeline, maximizes clinical trial outcomes and also interprets failures in trials of apparently promising drugs.
Under the terms of the agreement, Bayer Technology Services and Physiomics have committed themselves, under strict confidentiality, to undertake specific consulting projects according to customer requirements.
“We are delighted to be starting on this major collaborative project with Bayer,” said Physiomics CEO, Dr. John Savin. “We have made a considerable investment in the SystemCell technology and this collaboration is an excellent launchpad for us.”
“The collaboration with Physiomics strengthens our position as a technology leader in the field of predictive biological simulations.” said Dr. Helmut Mothes, Senior Vice President Bayer Technology Services. “Together, we are able to add significant value to the whole R&D value chain of our customers in the pharmaceutical and biotech industry.”
More details about Physiomics plc www.physiomics-plc.com
Bayer Technology Services: www.bayertechnology.com
